user

CARBOPLATIN AND GEMCITABINE IN ELDERLY AND/OR FRAIL PATIENTS (PTS) WITH ADVANCED TRANSITIONAL CELL CARCINOMA (TCC): A PHASE II STUDY

被引：0
|
作者：
Baitar, A. [1 ]
De Vos, M. [1 ]
Vandebroek, A. [1 ]
Schrijvers, D. [1 ]
机构：
[1] ZNA Middelheim, Dept Med Oncol, Antwerp, Belgium
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [31] First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study
    Tay, S. K.
    Ilanchadran, A.
    Tan, T. Y.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (12) : 1388 - 1392
  • [32] Carboplatin and gemcitabine in patients with advanced and/or metastatic urothelial cancers: A phase II study
    Baitar, Abdelbari
    De Vos, Machteld
    Vandebroek, An
    Schrijvers, Dirk
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2011, 2 (01) : 31 - 35
  • [33] Phase II trial of Gemcitabine-Carboplation combination in advanced transitional cell cancer (TCC) of bladder and urinary tract
    Sundar, Santhanam
    Sokal, Mike
    Lees, Kathryn
    Osborne, Lynne
    Carmichael, James
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 118 - 118
  • [34] Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma
    Yang, TS
    Lin, YC
    Chen, JS
    Wang, HM
    Wang, CH
    [J]. CANCER, 2000, 89 (04) : 750 - 756
  • [35] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Lin Run Wang
    Ming Zhu Huang
    Guo Bing Zhang
    Nong Xu
    Xiu Hua Wu
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 601 - 607
  • [36] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Wang, Lin Run
    Huang, Ming Zhu
    Zhang, Guo Bing
    Xu, Nong
    Wu, Xiu Hua
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 601 - 607
  • [37] Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium
    Hudson, E.
    Lester, J. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] PHASE II STUDY OF CARBOPLATIN IN LOCALLY ADVANCED AND METASTATIC TRANSITIONAL CELL-CARCINOMA OF THE URINARY-BLADDER
    RAABE, NK
    FOSSA, SD
    PARO, G
    [J]. BRITISH JOURNAL OF UROLOGY, 1989, 64 (06): : 604 - 607
  • [39] Phase II study of aflibercept (VEGF-Trap) in patients (pts) with recurrent or metastatic transitional cell carcinoma (TCC) of the urothelium: A California Cancer Consortium trial
    Twardowski, P.
    Stadler, W. M.
    Frankel, P.
    Lara, P. N.
    Ruel, C.
    Chatta, G.
    Heath, E. I.
    Quinn, D. I.
    Gandara, D. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] CALGB 90207: Phase II trial of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma (TCC).
    Rosenberg, J. E.
    Halabi, S.
    Sanford, B. L.
    Himelstein, A. L.
    Atkins, J. N.
    Hohl, R.
    Seagren, S. L.
    Bajorin, D. F.
    Small, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 237S - 237S
12345